Home › Encyclopedia › GHRP-6: Research Status, Identity, and Trial Data
Research / Unapproved

GHRP-6: Research Status, Identity, and Trial Data

Molecular formulaC46H56N12O6
Molecular weight873 g/mol
Registered trials0
PubChem CID4345065

Regulatory Status

GHRP-6 has no FDA-approved label and is classified as an unapproved research compound. No dosing or clinical use guidance exists for it in an approved context.

What GHRP-6 Is

GHRP-6 is a synthetic peptide with the molecular formula C46H56N12O6 and a molecular weight of approximately 873. It is catalogued under PubChem CID 4345065, which provides a chemical reference point but does not indicate approval status. Because there is no dailymed label on file, no mechanism of action, indication, or pharmacologic class can be sourced for this compound.

Trial Footprint

The clinicaltrials.gov record search returned zero registered trials for GHRP-6 at the time of this review. No sample studies are available to describe phase, design, or status.

FAQ

Is GHRP-6 FDA approved?
No. GHRP-6 has no FDA-approved label and is considered an unapproved research compound. No approved indications, dosing, or administration guidance exist for it.
What is GHRP-6 chemically?
GHRP-6 is a synthetic peptide with the molecular formula C46H56N12O6 and a molecular weight of about 873. It is listed in PubChem under CID 4345065.
Are there clinical trials studying GHRP-6?
As of the most recent data pull, clinicaltrials.gov listed zero registered trials for GHRP-6. This means no phase or status information is currently available for this compound.
What side effects are reported for GHRP-6?
No FAERS adverse event reports were available for GHRP-6 in the reviewed data. This absence reflects a lack of reporting data rather than a confirmed safety profile.
Does the absence of trials mean GHRP-6 is unsafe?
Not necessarily. It simply means there is no registered clinical trial data or FDA label information available to assess safety or effectiveness for this compound.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 4345065 ClinicalTrials.gov search results FDA FAERS (no data returned)

Updated 2026-09-19